男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

衰老關(guān)鍵蛋白1(FBLN1)重組蛋白

Recombinant Fibulin 1 (FBLN1)

  • 衰老關(guān)鍵蛋白1(FBLN1)重組蛋白產(chǎn)品包裝(模擬)
  • 衰老關(guān)鍵蛋白1(FBLN1)重組蛋白產(chǎn)品包裝(模擬)
  • 衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Figure . Gene Sequencing (extract)
  • RPC472Hu01.jpgSDS-PAGE圖
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPC472Hu02衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu03衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu01衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Hu02衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB
PAC472Hu01衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB; IHC; ICC; IP.
PAC472Hu03衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB
FAC472Hu01抗衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體Flow cytometry.
FAC472Hu03抗衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體Flow cytometry.
LAC472Hu71衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAC472Hu21衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體WB; IHC
MAC472Hu22衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體WB; IHC
FAC472Hu02抗衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體Flow cytometry.
LAC472Hu72衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
SEC472Hu衰老關(guān)鍵蛋白1(FBLN1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCC472Hu衰老關(guān)鍵蛋白1(FBLN1)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMC472Hu衰老關(guān)鍵蛋白1(FBLN1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSC472Hu01衰老關(guān)鍵蛋白1(FBLN1)抗體對(duì)ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Hu01衰老關(guān)鍵蛋白1(FBLN1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS?-?Clinical?ApplicationsComparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]